CCR5 receptor antagonist in tablet form for treatment-experienced patients with CCR5-tropic HIV-1. Manufactured by specialty pharmaceutical companies, distributed via specialized channels to outpatient clinics and AIDS care centers, acquired by clinicians for salvage therapy regimens.